Progestin replacement in the menopause: Effects on the endometrium and serum lipids

D. B. Williams, K. H. Moley

Research output: Contribution to journalReview article

21 Scopus citations

Abstract

The benefits of estrogen replacement therapy (ERT) in the menopause have been well demonstrated and are of significant importance, particularly with regard to prevention of osteoporosis and reduction in cardiovascular morbidity and mortality. The addition of a progestin to ERT is advocated in patients with a uterus to minimize the risk of endometrial hyperplasia and cancer. Although progestins can have adverse effects on serum lipids, it is unclear whether or not these effects negate the cardioprotective effects of estrogen. Progestins are an important part of hormone replacement therapy (HRT) regimen in patients with an intact uterus. The minimum dose and duration should be given to offset potential adverse effects on serum lipids while affording adequate protection of the endometrium. Both continuous and sequential progestin regimens appear to be efficacious. The newer progestins may offer increased flexibility in minimizing progestin side-effects while protecting the endometrium. Other regimens, such as less than monthly progestin administration, may offer another alternative to achieve these goals. Future studies in these areas are warranted.

Original languageEnglish
Pages (from-to)284-292
Number of pages9
JournalCurrent Opinion in Obstetrics and Gynecology
Volume6
Issue number3
StatePublished - Jan 1 1994

Fingerprint Dive into the research topics of 'Progestin replacement in the menopause: Effects on the endometrium and serum lipids'. Together they form a unique fingerprint.

Cite this